Incyte Data at the European Academy of Dermatology and Venereology (EADV) Congress Underscore the Breadth of Incyte’s Inflammation and Autoimmunity Portfolio
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| Incyte Genomics, Inc. (NASDAQ: INCY) | Delayed: 115.71 -1.22 (1.04%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $116.93 | 52 Week High | $118.49 | |||
| Open | $116.75 | 52 Week Low | $55.00 | |||
| Day High | $116.87 | P/E | N/A | |||
| Day Low | $115.12 | EPS | $-0.56 | |||
| Volume | 1,476,823 | |||||
